Literature DB >> 9874248

Selective coupling of STAT factors to the mouse prolactin receptor.

S Mayr1, T Welte, M Windegger, J Lechner, P May, P C Heinrich, F Horn, W Doppler.   

Abstract

Prolactin has been reported to induce distinct sets of signal transducers and activators of transcription (STAT) in a cell-type-specific fashion. In the mammary epithelium, although STAT1, STAT3, STAT5A, STAT5B and STAT6 are present in a latent form, only STAT5A and STAT5B are activated. This selective activation of STAT5 by prolactin was also observed in COS-7 cells cotransfected with the long form of the mouse prolactin receptor (PRL-R) and expression vectors for STAT1, STAT3, STAT5 and STAT6. Mutated PRL-Rs and chimeric erythropoietin/gp130 (EPO/gp130) receptors with a tyrosine-containing motif attached at the carboxy terminus were employed to determine the sites in the PRL-R required for the specific activation of STAT5. The experiments revealed the importance of two motifs containing Y477 and Y578 in the PRL-R. When linked to the EPO/gp130 receptor, these sequences were sufficient to specifically induce DNA binding of STAT5 and to activate transcription from the beta-casein gene promoter. By contrast, only weakly they induced DNA binding of STAT6 and STAT3 and did not induce STAT1. A synthetic nonapeptide with phosphorylated Y477 was able to disrupt STAT5 DNA binding in vitro. Our results define structural domains within the carboxy terminus of the PRL-R which recruit STAT5 for signalling and which are capable of distinguishing STAT5 from other STAT proteins. The activity of STAT5 forms with deletions of the carboxy terminus was induced more strongly than that of their full-length counterparts 2 min after activation of the PRL-R. This effect was not dependent on the presence of Y477 and Y578 in the PRL-R, indicating that facilitated activation of short STAT5 isoforms relies on mechanisms other than increased coupling to specific regions of the PRL-R.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874248     DOI: 10.1046/j.1432-1327.1998.2580784.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5.

Authors:  W Doppler; M Windegger; C Soratroi; J Tomasi; J Lechner; S Rusconi; A C Cato; T Almlöf; J Liden; S Okret; J A Gustafsson ; H Richard-Foy; D B Starr; H Klocker; D Edwards; S Geymayer
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  Perturbation of beta1-integrin function in involuting mammary gland results in premature dedifferentiation of secretory epithelial cells.

Authors:  Marisa M Faraldo; Marie-Ange Deugnier; Sylvie Tlouzeau; Jean Paul Thiery; Marina A Glukhova
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

3.  Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B/C interaction.

Authors:  Philip J Jensik; Lydia A Arbogast
Journal:  Mol Cell Endocrinol       Date:  2014-11-04       Impact factor: 4.102

4.  Lack of toxicity of a STAT3 decoy oligonucleotide.

Authors:  Malabika Sen; Patricia J Tosca; Christa Zwayer; Michael J Ryan; Jerry D Johnson; Katherine A B Knostman; Patricia C Giclas; James O Peggins; Joseph E Tomaszewski; Timothy P McMurray; Changyou Li; Michael S Leibowitz; Robert L Ferris; William E Gooding; Sufi M Thomas; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancer Chemother Pharmacol       Date:  2008-09-03       Impact factor: 3.333

5.  IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter.

Authors:  R M Lowe; A Genin; N Orgun; R Q Cron
Journal:  Genes Immun       Date:  2014-02-06       Impact factor: 2.676

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.